Hospital
ST Vincent Salem Hospital INC
ST Vincent Salem Hospital INC was paid $4.39M by Medicaid between Jan 2018 and Nov 2024, across 64 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoST VINCENT SALEM HOSPITAL INC
SALEM, IN 47167
SALEM, IN 47167
33aNPI1427388982assigned 01/06/2010
33bProvider typeCritical Access Hospital
28Total paid$4.39M
24GClaims78,032
24DCodes billed64
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#12 of 26
Median peer was paid$4.16M
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,351 | $225K | |
| 2019 | 7,298 | $313K | |
| 2020 | 9,878 | $506K | |
| 2021 | 14,351 | $836K | |
| 2022 | 18,015 | $1.09M | |
| 2023 | 11,923 | $901K | |
| 2024incomplete | 6,216 | $521K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 8,957 | 8,082 | $1.28M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 24% | 1,376 | 1,069 | $1.05M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 6,891 | 5,718 | $651K |
| 43450 | 5.3% | 1,220 | 939 | $234K | |
| 71045 | Radiologic examination, chest; single view | 5.2% | 2,051 | 1,674 | $228K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.0% | 3,048 | 2,672 | $221K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.8% | 2,286 | 1,881 | $123K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.3% | 944 | 703 | $103K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 2,139 | 1,899 | $85K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 1,076 | 968 | $68K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 1,762 | 1,424 | $63K |
| 80053 | Comprehensive metabolic panel | 1.2% | 9,890 | 7,987 | $53K |
52 more codes
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 1.0% | 32 | $46K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 12,320 | $44K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 618 | $34K |
| 84484 | <1% | 2,661 | $16K | |
| 94060 | <1% | 152 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,465 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 108 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 75 | $8K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 121 | $7K |
| 87634 | <1% | 149 | $6K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 26 | $6K |
| 83690 | <1% | 1,677 | $5K | |
| 83880 | <1% | 354 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 308 | $4K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 886 | $3K |
| 83605 | <1% | 452 | $3K | |
| 81001 | <1% | 2,033 | $3K | |
| 80306 | <1% | 298 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 317 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 14 | $2K |
| 82553 | <1% | 510 | $2K | |
| 82550 | <1% | 505 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 37 | $1K |
| 87040 | <1% | 237 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 259 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,640 | $767.65 |
| 83735 | <1% | 165 | $663.81 | |
| 88342 | <1% | 1,325 | $444.88 | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 85 | $399.97 |
| 85379 | <1% | 78 | $350.70 | |
| 82150 | <1% | 82 | $338.25 | |
| 85730 | <1% | 96 | $334.27 | |
| 85610 | <1% | 112 | $276.25 | |
| 87088 | <1% | 29 | $114.38 | |
| 87430 | <1% | 15 | $110.81 | |
| 87081 | <1% | 154 | $82.20 | |
| 81003 | <1% | 21 | $72.15 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13 | $60.84 |
| 80069 | <1% | 13 | $59.88 | |
| 88313 | <1% | 720 | $16.20 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 507 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 508 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 487 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 14 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 45 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 74 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 360 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 42 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 38 | $0.00 |
| 94729 | 0% | 107 | $0.00 | |
| 88312 | 0% | 36 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMUNTZ, DANA (ADMINISTRATOR/CNO)